| CIREX | SGIIX | CIREX / SGIIX | |
| Total Expense Ratio | 0.85 | 0.86 | 99% |
| Annual Report Gross Expense Ratio | 0.85 | 0.86 | 99% |
| Fund Existence | 24 years | 27 years | - |
| Gain YTD | 13.821 | 21.540 | 64% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 250 | 1000000 | 0% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 121B | 71.4B | 169% |
| Annual Yield % from dividends | 2.60 | 1.98 | 131% |
| Returns for 1 year | 12.87 | 20.27 | 63% |
| Returns for 3 years | 32.31 | 46.03 | 70% |
| Returns for 5 years | 42.42 | 43.35 | 98% |
| Returns for 10 years | 84.40 | 71.96 | 117% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| HEZU | 43.88 | 0.13 | +0.29% |
| iShares Currency Hedged MSCI Eurozn ETF | |||
| STXG | 51.56 | 0.08 | +0.16% |
| Strive 1000 Growth ETF | |||
| GQQQ | 30.40 | -0.01 | -0.02% |
| Astoria US Quality Growth Kings ETF | |||
| FNDA | 32.12 | -0.01 | -0.03% |
| Schwab Fundamental U.S. Small CompanyETF | |||
| FTXH | 33.49 | -0.04 | -0.13% |
| First Trust Nasdaq Pharmaceuticals ETF | |||